News | September 22, 2021
Kotak Mahindra offers financing options for healthcare
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people
Ind-Ra expects IPM revenue to grow over 12% YoY in FY22
The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour
The Covid-19 pandemic has exposed the divide that exists between rich and developing nations and to address these challenges the World Health Organisation (WHO), has compiled a list of innovative health technologies that aim to bridge the gap
The segment delivered strong sales growth of 20% YoY
The facility has the capacity to produce one crore doses per day
The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
Subscribe To Our Newsletter & Stay Updated
